EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells

Mingyong Tan, Hanbing Shao, Xinan Zhang iD, Yuyao Cheng, Zhimeng Sun, Ming Yang, Siyuan Mu, Weishi Liang, Bo Han, Xinfeng Wu, Xiaohui Liu, Yong Hai und 2 weitere

Proceedings of the National Academy of Sciences · 28.07.2026 · 123 (30)

DOI: 10.1073/pnas.2533427123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.07.2026. Verfasst von Mingyong Tan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: beta-Arrestin 1, Sphingosine-1-Phosphate Receptors, beta-Alanine, Colorectal Neoplasms. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-fluoro-β-alanine (FBAL), a catabolite of the chemotherapeutic agent 5-fluorouracil (5-FU), has attracted significant attention due to its cardiotoxicity and neurotoxicity. However, its association with 5-FU resistance, a major obstacle in cancer treatment, has rarely been reported. In this study, FBAL was identified as a β-arrestin1-biased ligand of sphingosine 1-phosphate receptor 2 (S1PR2), which upregulates dihydropyrimidine dehydrogenase (DPD) expression and drives 5-FU resistance in colorectal cancer. Mechanistically, following exposure to FBAL, S1PR2, a G protein–coupled receptor (GPCR), is phosphorylated by recruiting G protein–coupled receptor kinase 6 (GRK6). Phosphorylated S1PR2 coupled with β-arrestin1, but not G proteins, to activate the MEK/ERK/AP-1 pathway and promote DPYD transcription. Ser343 was identified as the key phosphorylation site of S1PR2 using IP-MS analysis. This residue within the C-terminal domain mediates receptor interaction with β-arrestin-1 to activate the β-arrestin-1-dependent ERK pathway, as was confirmed in HCT116 S1PR2KO-ΔC cells and HCT116 S1PR2KO-S343A cells. In vivo , mice bearing orthotopic xenografts of HCT116 S1PR2KO-S343A cells exhibited significantly enhanced higher sensitivity to 5-FU treatment compared to those HCT116 S1PR2KO-WT cells following FBAL. Taken together, this study showed that exposure to FBAL induces S1PR2 phosphorylation at Ser343 within the C-terminal mediated by GRK6, activating the β-arrestin1-dependent ERK pathway to upregulate DPD expression. This study not only delineates a phosphorylation-dependent signaling pathway in chemoresistance but also establishes S1PR2 as a promising therapeutic target for overcoming 5-FU resistance in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-Arrestin 1Sphingosine-1-Phosphate Receptorsbeta-AlanineColorectal NeoplasmsReceptors, LysosphingolipidHumansAnimalsPhosphorylationMiceCell Line, TumorFluorouracilLigandsUp-RegulationDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticG-Protein-Coupled Receptor Kinases

Stichwörter der Autor:innen

G protein–coupled receptor kinase 6phosphorylationsphingosine 1-phosphate receptor 2α-fluoro-β-alanineβ-arrestin-1

Substanzen

beta-Arrestin 1Sphingosine-1-Phosphate ReceptorsS1PR2 protein, humanFluorouracilbeta-AlanineLigandsG-protein-coupled receptor kinase 6Receptors, LysosphingolipidG-Protein-Coupled Receptor Kinases

Autor:innen und Institutionen

  • Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing 100069, China.
  • Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
  • Joint Laboratory for Research and Treatment of Spinal Cord Injury in Spinal Deformity, Capital Medical University, Beijing 100069, China.
  • Department of Orthopedic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.

ORCID-Profile: Xinan Zhang, Shuxiang Cui, Xianjun Qu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Tan, M., Shao, H., Zhang, X., Cheng, Y., Sun, Z., Yang, M., Mu, S., Liang, W., Han, B., Wu, X., Liu, X., Hai, Y., Cui, S., & Qu, X. (2026). α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells. Proceedings of the National Academy of Sciences, 123(30). https://doi.org/10.1073/pnas.2533427123

Vancouver

Tan M, Shao H, Zhang X, Cheng Y, Sun Z, Yang M, et al. α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells. Proceedings of the National Academy of Sciences. 2026;123(30). doi:10.1073/pnas.2533427123

BibTeX
@article{Tan2026,
  author = {Tan, Mingyong and Shao, Hanbing and Zhang, Xinan and Cheng, Yuyao and Sun, Zhimeng and Yang, Ming and Mu, Siyuan and Liang, Weishi and Han, Bo and Wu, Xinfeng and Liu, Xiaohui and Hai, Yong and Cui, Shuxiang and Qu, Xianjun},
  title = {α-fluoro-β-alanine functions as a β-arrestin1-biased ligand of S1PR2 to upregulate DPD expression in cancer cells},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {30},
  doi = {10.1073/pnas.2533427123}
}
Kostenlos starten →